Icon Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Icon Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$412K	Sell	783 -53	-6%	-$29.7K	0.02%	295
2026 Q1	$463K	Sell	836 -3,083	-79%	-$1.98M	0.03%	265
2025 Q4	$2.65M	Sell	3,919 -161	-4%	-$110K	0.18%	89
2025 Q3	$2.61M	Sell	4,080 -873	-18%	-$530K	0.18%	89
2025 Q2	$2.66M	Buy	4,953 +4,378	+761%	+$2.09M	0.19%	89
2025 Q1	$241K	Buy	575 +41	+8%	+$17.8K	0.02%	317
2024 Q4	$221K	Buy	534 +11	+2%	+$4.83K	0.02%	355
2024 Q3	$264K	Buy	+523	New	+$254K	0.02%	310
2024 Q2	–	Sell	-362	Closed	-$195K	–	467
2024 Q1	$195K	Hold	362	–	–	0.02%	341
2023 Q4	$201K	Buy	+362	New	+$170K	0.02%	322

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Icon Wealth Advisors's IDXX Position: Q2 2026 in Review

Icon Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 6.3% in Q2 2026, selling an estimated $29.7K and leaving 783 shares worth $412K. The position accounts for 0.02% of the portfolio, ranked #295.

Icon Wealth Advisors first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.66M in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Icon Wealth Advisors held 783 shares of Idexx Laboratories worth $412K as of Q2 2026.
Icon Wealth Advisors sold 53 Idexx Laboratories shares in Q2 2026, an estimated $29.7K.
Idexx Laboratories made up 0.02% of Icon Wealth Advisors's portfolio in Q2 2026, its #295 holding.
Icon Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
Icon Wealth Advisors's Idexx Laboratories position peaked at $2.66M in Q2 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Icon Wealth Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.